Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity

Int J Obes Relat Metab Disord. 2000 Nov;24(11):1392-5. doi: 10.1038/sj.ijo.0801398.

Abstract

Objective: To study whether weight reducing treatment modulates serum concentration of TNF-alpha and two soluble TNF-alpha receptors in obese subjects.

Subjects and measurements: Serum concentrations of TNF-alpha and two soluble receptors (sTNF-R1, sTNF-R2), plasma glucose, insulin, total cholesterol, HDL-cholesterol and triglicerides were measured in 27 obese subjects (age 48 +/- 12y, body mass index (BMI): 36 +/- 6 kg/m2) before and after 3 months weight reducing treatment consisted of a diet & 1,000 kcal/day and physical exercises.

Results: The mean loss of weight during 3 months' treatment was 9.3 +/- 3.3 kg. The serum concentration of TNF-alpha decreased after weight loss and at the same time both of the receptors (sTNF-R1,sTNF-R2) increased significantly.

Conclusion: The observed decrease of the serum concentration of TNF-alpha and the increase in both TNF soluble receptors after weight reducing treatment in obese subjects, may be a counter-regulation preventing further weight loss.

MeSH terms

  • Body Mass Index
  • Diet, Reducing*
  • Exercise
  • Female
  • Humans
  • Insulin Resistance
  • Lipids / blood
  • Male
  • Middle Aged
  • Obesity / blood*
  • Obesity / diet therapy
  • Receptors, Tumor Necrosis Factor / blood*
  • Tumor Necrosis Factor-alpha / metabolism*
  • Weight Loss / physiology

Substances

  • Lipids
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha